ClinicalTrials.Veeva

Menu

COVID-19 Post-Vaccination Observation

Y

Yang I. Pachankis, PhD

Status

Active, not recruiting

Conditions

Immune System Disorder
COVID-19 Vaccine Adverse Reaction
Immune System Diseases

Study type

Observational

Identifiers

NCT06107348
SARS-Immune-00

Details and patient eligibility

About

The study started after the second COVID-19 vaccination of the participant with blood spots appearing on the skin with severe arthritis. The study continued to the third-dose full vaccination of the participant with the recombined COVID-19 vaccination and afterwards. The study completed until intervention.

Enrollment

1 patient

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

All COVID-19 vaccinated are eligible for inclusion.

Trial design

1 participants in 1 patient group

Immune Disorder

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems